Physician profile
Erika Sofia Fulop
NPI 1174114011
$1,752.36
in general payments reported to CMS, 2019-2025
22 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $932 · 2022: $477 · 2023: $108 · 2024: $32.65 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $290.72 | 2021-2025 | Talicia, Movantik, Aemcolo |
| Novo Nordisk INC | $281.49 | 2021-2025 | Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.08 | 2021-2022 | |
| Eisai INC. | $115.01 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.01 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $78.44 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $75.07 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $64.73 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.18 | 2022 | |
| Lilly USA, LLC | $57.72 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $57.23 | 2021-2022 | |
| Organon LLC | $52.85 | 2022-2025 | Nexplanon |
| Pfizer INC. | $51.57 | 2023-2025 | |
| Sanofi Pasteur INC. | $48.62 | 2021-2022 | |
| Exact Sciences Corporation | $41.07 | 2025 | Cologuard Collection Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $36.17 | 2021-2025 | Immunocap |
| Esperion Therapeutics, INC. | $28.46 | 2021 | |
| Cipher Pharmaceuticals US LLC | $28.37 | 2025 | Spinosad, Natroba |
| Hologic Sales and Service, LLC | $24.32 | 2025 | Thinprep 2000 Processor, Aptima |
| Shield Therapeutics INC | $17.22 | 2023 | Accrufer |
| Amgen INC. | $13.54 | 2023 | Repatha, Otezla |
| Amarin Pharma, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Fulop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.